Domperidone is dopamine receptor (D2) antagonist which selectively inhibits dopamine at the D2 receptor. It acts principally at receptors in the chemoreceptor trigger zone (CTZ) and also at receptors in the stomach.
(in Tablet form)
Adults: 10 – 20 mg every 4 – 8 hours daily
Children: 0.2 – 0.4 mg/kg every 4 – 8 hours daily.
Domperidone tablet and suspension should be taken 15 – 30 minutes before a meal. For acute nausea and vomiting, maximum period of treatment is 12 weeks.
Manufacturer: Square Pharmaceutical Ltd.